<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font28 { font-size : 28; } .font29 { font-size : 29; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">HCV </span>
   <span class="font31">participants </span>
   <span class="font29">(%) </span>
   <span class="font28">study </span>
   <span class="font25">SHARED�? </span>
   <span class="font24">laboratory </span>
   <span class="font19">treatment </span>
   <span class="font19">monitoring </span>
   <span class="font18">{border-style </span>
   <span class="font17">results </span>
   <span class="font17">px;} </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">hepatitis </span>
   <span class="font16">therapy </span>
   <span class="font15">clinical </span>
   <span class="font15">grade </span>
   <span class="font15">on�?treatment </span>
   <span class="font14">participant </span>
   <span class="font14">virus </span>
   <span class="font14">adherence </span>
   <span class="font14">weeks </span>
   <span class="font14">efficacy </span>
   <span class="font14">genotype </span>
   <span class="font14">limited </span>
   <span class="font14">safety </span>
   <span class="font14">viral </span>
   <span class="font13">AEs </span>
   <span class="font13">Rwanda </span>
   <span class="font13">Study </span>
   <span class="font13">access </span>
   <span class="font13">levels </span>
   <span class="font13">patients </span>
   <span class="font13">DAA </span>
   <span class="font13">Health </span>
   <span class="font13">SVR </span>
   <span class="font13">health </span>
   <span class="font13">load </span>
   <span class="font13">px; </span>
   <span class="font13">{font-family </span>
   <span class="font12">CI: </span>
   <span class="font12">Hepatitis </span>
   <span class="font12">compared </span>
   <span class="font12">did </span>
   <span class="font12">font-size </span>
   <span class="font12">renal </span>
   <span class="font12">similar </span>
   <span class="font12">simplified </span>
   <span class="font12">(%; </span>
   <span class="font12">(i.e., </span>
   <span class="font12">Accessed </span>
   <span class="font12">Available </span>
   <span class="font12">HIV </span>
   <span class="font12">adverse </span>
   <span class="font12">blinded </span>
   <span class="font12">double; </span>
   <span class="font12">efficacy, </span>
   <span class="font12">lab </span>
   <span class="font12">primary </span>
   <span class="font12">prior </span>
   <span class="font12">rate </span>
   <span class="font12">rates </span>
   <span class="font12">using </span>
   <span class="font12">Association </span>
   <span class="font12">CBC </span>
   <span class="font12">However, </span>
   <span class="font12">Liver </span>
   <span class="font12">Med;:�?. </span>
   <span class="font12">Published </span>
   <span class="font12">ZeuzemS, </span>
   <span class="font12">at: </span>
   <span class="font12">based </span>
   <span class="font12">blood </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">chronic </span>
   <span class="font12">clinician </span>
   <span class="font12">collab: </span>
   <span class="font12">cost </span>
   <span class="font12">count </span>
   <span class="font12">criteria </span>
   <span class="font12">direct�?acting </span>
   <span class="font12">enrolled </span>
   <span class="font12">guidelines </span>
   <span class="font12">high </span>
   <span class="font12">including </span>
   <span class="font12">increased </span>
   <span class="font12">individuals </span>
   <span class="font12">infection </span>
   <span class="font12">need </span>
   <span class="font12">patient </span>
   <span class="font12">performed </span>
   <span class="font12">proportion </span>
   <span class="font12">response </span>
   <span class="font12">result </span>
   <span class="font12">routine </span>
   <span class="font12">safety, </span>
   <span class="font12">solid; </span>
   <span class="font12">support </span>
   <span class="font12">total </span>
   <span class="font12">week </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">Baseline </span>
   <span class="font11">Committee </span>
   <span class="font11">EASL </span>
   <span class="font11">Gilead </span>
   <span class="font11">Hepatol;:�?. </span>
   <span class="font11">LDV/SOF </span>
   <span class="font11">March </span>
   <span class="font11">SHARED </span>
   <span class="font11">Treatment </span>
   <span class="font11">abdominal </span>
   <span class="font11">antiviral </span>
   <span class="font11">bold </span>
   <span class="font11">completion </span>
   <span class="font11">courier; </span>
   <span class="font11">determined </span>
   <span class="font11">em; </span>
   <span class="font11">entry </span>
   <span class="font11">event </span>
   <span class="font11">evidence </span>
   <span class="font11">facilitate </span>
   <span class="font11">generic </span>
   <span class="font11">improve </span>
   <span class="font11">infection. </span>
   <span class="font11">initiation </span>
   <span class="font11">ledipasvir </span>
   <span class="font11">liver </span>
   <span class="font11">log </span>
   <span class="font11">low </span>
   <span class="font11">lower </span>
   <span class="font11">median </span>
   <span class="font11">outcomes </span>
   <span class="font11">overall </span>
   <span class="font11">participants. </span>
   <span class="font11">pill </span>
   <span class="font11">provided </span>
   <span class="font11">pt;} </span>
   <span class="font11">received </span>
   <span class="font11">recommended </span>
   <span class="font11">significant </span>
   <span class="font11">simplification </span>
   <span class="font11">study. </span>
   <span class="font11">subtype </span>
   <span class="font11">sub�?Saharan </span>
   <span class="font11">tolerability </span>
   <span class="font11">tolerability, </span>
   <span class="font11">treated </span>
   <span class="font11">treatment, </span>
   <span class="font11">treatment. </span>
   <span class="font11">unblinding </span>
   <span class="font11">virologic </span>
  </p>
 </body>
</html>
